Inventor · disambiguated record
Norman Kong
Also filed as: KONG NORMAN · KONG NORMAN XIANGLONG
28 granted patents·3 pending applications·314 citations·filing 1998–2021
95Inventor score
Files withHOFFMANN LA ROCHE14BEIJING INNOCARE PHARMA TECH CO LTD5MERCK SHARP & DOHME5NANJING INNOCARE PHARMA TECH CO LTD2ANDERSON KEVIN W1
Top patents by PatentIndex Score
31 records- 0197US7851626B24,4,5,5, tetrasubstituted imidazolinesHOFFMANN LA ROCHE·Filed 2006·Granted Dec 14, 2010·43 cites·33 claims
- 0296US7893278B2CIS-imidazolinesHOFFMANN LA ROCHE·Filed 2005·Granted Feb 22, 2011·43 cites·7 claims
- 0394US6734302B2Cis-imidazolinesHOFFMANN LA ROCHE·Filed 2002·Granted May 11, 2004·89 cites·41 claims
- 0493US6617346B1Cis-imidazolinesHOFFMANN LA ROCHE·Filed 2002·Granted Sep 9, 2003·68 cites·11 claims
- 0592US11572353B2Alkynyl-substituted heterocyclic compound, preparation method therefor and medical use thereofBEIJING INNOCARE PHARMA TECH CO LTD·Filed 2021·Granted Feb 7, 2023·2 cites·17 claims
- 0690US7425638B2Cis-imidazolinesHOFFMANN LA ROCHE·Filed 2004·Granted Sep 16, 2008·31 cites·5 claims
- 0784US7371869B2Substituted hydantoinsHOFFMANN LA ROCHE·Filed 2005·Granted May 13, 2008·9 cites·5 claims
- 0883US10590109B2Heterocyclic compounds used as FGFR inhibitorsNANJING INNOCARE PHARMA TECH CO LTD·Filed 2019·Granted Mar 17, 2020·4 cites·8 claims
- 0975US6013242ATropane derivatives with selective binding to the serotonin reuptake transporters for treatment of mental illness and as intermediates in the formation of imaging diagnostic agents for depressionUNIV WAKE FOREST·Filed 1998·Granted Jan 11, 2000·18 cites·21 claims
- 1071US10710981B2Alkynyl-substituted heterocyclic compound, preparation method therefor and medical use thereofBEIJING INNOCARE PHARMA TECH CO LTD·Filed 2019·Granted Jul 14, 2020·0 cites·20 claims
- 1171US9725445B2Cycloalkyl nitrile pyrazolo pyridones as Janus kinase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Aug 8, 2017·2 cites·17 claims
- 1269US11059805B2Alkynyl-substituted heterocyclic compound, preparation method therefor and medical use thereofBEIJING INNOCARE PHARMA TECH CO LTD·Filed 2020·Granted Jul 13, 2021·0 cites·6 claims
- 1366US9957264B2Geminally substituted cyanoethylpyrazolo pyridones as Janus kinase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted May 1, 2018·1 cites·9 claims
- 1465US6559164B1Substituted pyrroles suitable for continuous infusionHOFFMANN LA ROCHE·Filed 2000·Granted May 6, 2003·3 cites·24 claims
- 1562US6281356B1Substituted pyrrolesHOFFMANN LA ROCHE·Filed 2000·Granted Aug 28, 2001·1 cites·87 claims
- 1654US2023271959A1Heterocyclic compound as bcl-2 inhibitorBEIJING INNOCARE PHARMA TECH CO LTD·Filed 2021·Application pending·0 cites
- 1751US7612212B2Substituted hydantoinsHOFFMANN LA ROCHE·Filed 2007·Granted Nov 3, 2009·0 cites·16 claims
- 1849US9802920B2Inhibitors of bruton's tyrosine kinaseHOFFMANN LA ROCHE·Filed 2014·Granted Oct 31, 2017·0 cites·23 claims
- 1948US9556150B2Inhibitors of bruton's tyrosine kinaseHOFFMANN LA ROCHE·Filed 2014·Granted Jan 31, 2017·0 cites·18 claims
- 2048US7557221B2Substituted hydantoinsHOFFMANN LA ROCHE·Filed 2008·Granted Jul 7, 2009·0 cites·10 claims
- 2147US11878987B2Heterocyclic compound as TRK inhibitorBEIJING INNOCARE PHARMA TECH CO LTD·Filed 2019·Granted Jan 23, 2024·0 cites·10 claims
- 2246US10752631B2Heterocyclic compounds as FGFR inhibitorsGUANGZHOU INNOCARE PHARMA TECH CO LTD·Filed 2017·Granted Aug 25, 2020·0 cites·20 claims
- 2344US9394263B2Substituted hetero-azepinonesHOFFMANN LA ROCHE·Filed 2013·Granted Jul 19, 2016·0 cites·19 claims
- 2444US8063085B2Substituted hydantoinsCHEN SHAOQING·Filed 2008·Granted Nov 22, 2011·0 cites·23 claims
- 2543US10059705B2Acyclic cyanoethylpyrazolo pyridones as janus kinase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Aug 28, 2018·0 cites·7 claims
- 2643US9957265B2N-(2-cyano heterocyclyl) pyrazolo pyridones as janus kinase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted May 1, 2018·0 cites·11 claims
- 2743US7427635B2Substituted hydantoinsHOFFMANN LA ROCHE·Filed 2005·Granted Sep 23, 2008·0 cites·5 claims
- 2843US2004204410A1CIS-imidazolinesFiled 2004·Application pending·0 cites
- 2939US10072025B2Ethyl N-boc piperidinyl pyrazolo pyridones as Janus kinase inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Sep 11, 2018·0 cites·17 claims
- 3036US8314250B2Sultam derivativesANDERSON KEVIN W·Filed 2010·Granted Nov 20, 2012·0 cites·37 claims
- 3135US2022289719A1Heterocyclic compounds as mnk inhibitorsNANJING INNOCARE PHARMA TECH CO LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Norman Kong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →